Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developedBy |
gptkb:Spero_Therapeutics
|
| gptkbp:drugClass |
gptkb:antibiotic
fluoroquinolone |
| https://www.w3.org/2000/01/rdf-schema#label |
SPT 621
|
| gptkbp:indication |
urinary tract infection
complicated urinary tract infection |
| gptkbp:mechanismOfAction |
inhibits bacterial DNA gyrase and topoisomerase IV
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:status |
investigational
|
| gptkbp:bfsParent |
gptkb:Strathaven
|
| gptkbp:bfsLayer |
7
|